NCT03480594View on ClinicalTrials.gov

Effect of Fatty Liver on TCA Cycle Flux and the Pentose Phosphate Pathway

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

October 13, 2023

Study Completion Date

October 13, 2023

Conditions
Fatty Liver
Interventions
DRUG

MRI Tracer

Hyperpolarized \[1-13C\] pyruvate for injection under IND133229 used to enhance MRI/MRS/MRSI using a 3T MRI scanner.

Trial Locations (1)

75390-8568

Advanced Imaging Research Center, Dallas

All Listed Sponsors
collaborator

National Institute for Biomedical Imaging and Bioengineering (NIBIB)

NIH

lead

University of Texas Southwestern Medical Center

OTHER

NCT03480594 - Effect of Fatty Liver on TCA Cycle Flux and the Pentose Phosphate Pathway | Biotech Hunter | Biotech Hunter